Several gurus are focusing on stocks whose Peter Lynch fair values are far above their current prices, according to the GuruFocus All-in-One Screener. As of Thursday, the following companies are trading with wide margins of safety and have had positive performance over the last 12 months.
Bristol-Myers Squibb Company (BMY, Financial) is trading around $50.83 per share. The Peter Lynch value gives the stock a fair price of $80.04, which suggests it is undervalued with a 36% margin of safety. Over the last three months, the stock has registered a positive performance of 11.29%.
The company, which develops and markets pharmaceutical products, has a market cap of $83.15 billion and an enterprise value of $78.94 billion.
The stock is trading with a price-earnings ratio of 13.38, which is higher than 70% of companies in the Drug Manufacturers industry. The stock price is currently 19.76% below its 52-week high and 19.66% above its 52-week low. The price-book ratio is 5.14.
The company's largest guru shareholder is the Vanguard Health Care Fund (Trades, Portfolio) with 3.12% of outstanding shares, followed by Dodge & Cox with 3.08% and PRIMECAP Management (Trades, Portfolio) with 1.33%.
Sony Corp. (SNE, Financial) is trading around $57.87 per share. The Peter Lynch value gives the stock a fair price of $151.77, which suggests it is undervalued with a 62% margin of safety. The stock registered a positive three-month performance of 6.42%.
The company has a market cap of $71.20 billion and an enterprise value of $69.93 billion.
The stock is trading with a price-earnings ratio of 9.5, which is higher than 80% of companies in the Computer Hardware industry. The stock price is currently 13.65% below its 52-week high and 26.38% above its 52-week low. The price-book ratio is 2.01.
PRIMECAP Management is the company's largest guru shareholder with 3.27% of outstanding shares, followed by Jim Simons (Trades, Portfolio)’ Renaissance Technologies with 0.30%, Mario Gabelli (Trades, Portfolio) with 0.30% and Daniel Loeb (Trades, Portfolio) with 0.12%.
Celgene Corp. (CELG, Financial) is trading around $100 per share. The Peter Lynch value gives the stock a fair price of $182.5, which suggests it is undervalued with a 68% margin of safety. Over the last three months, the stock has risen 6.20%.
The biopharmaceutical company has a market cap of $70.61 billion and an enterprise value of $81.08 billion.
The stock is trading with a price-earnings ratio of 13.65, which is higher than 65% of companies in the Drug Manufacturers industry. The stock price is currently 0.79% below its 52-week high and 70.05% above its 52-week low. The price-book ratio is 6.94.
The company's largest guru shareholder is Simons’ firm with 1.26% of outstanding shares, followed by David Abrams (Trades, Portfolio) with 0.95%, John Paulson (Trades, Portfolio) with 0.47% and Paul Tudor Jones (Trades, Portfolio) with 0.16%.
Applied Materials Inc. (AMAT, Financial) is trading around $51 per share. The Peter Lynch value gives the stock a fair price of $75, which suggests it is undervalued with a 32% margin of safety. Over the last three months, the stock has registered a positive performance of 16.10%.
The provider of semiconductor manufacturing equipment has a market cap of $47.41 billion and an enterprise value of $48.71 billion.
The stock is trading with a price-earnings ratio of 17.17, which is higher than 57% of companies in the Semiconductors industry. The stock price is currently 3.38% below its 52-week high and 76.59% above its 52-week low. The price-book ratio is 5.87.
Chris Davis (Trades, Portfolio) is the company's largest guru shareholder with 1.70% of outstanding shares, followed by the Parnassus Endeavor Fund (Trades, Portfolio) with 0.72% and PRIMECAP Management with 0.54%.
Lam Research Corp. (LRCX, Financial) is trading around $236 per share. The Peter Lynch value gives the stock a fair price of $343, which suggests it is undervalued with a 32% margin of safety. Over the last three months, the stock has risen 27.97%.
The company, which provides equipment for fabricating semiconductors, has a market cap of $33.77 billion and an enterprise value of $32.82 billion.
The stock is trading with a price-earnings ratio of 17, which is higher than 56% of companies in the Semiconductors industry. The stock price is currently 4.84% below its 52-week high and 90.09% above its 52-week low. The price-book ratio is 7.53.
The company's largest guru shareholder is the Parnassus Endeavor Fund with 0.71% of outstanding shares, followed by Pioneer Investments (Trades, Portfolio) with 0.70%, Simons’ firm with 0.33% and Joel Greenblatt (Trades, Portfolio) with 0.12%.
NXP Semiconductors NV (NXPI, Financial) is trading around $106 per share. The Peter Lynch value gives the stock a fair price of $156.66, which suggests it is undervalued with a 32% margin of safety. Over the last three months, the stock has registered a positive performance of 10.86%.
The semiconductor company has a market cap of $29.54 billion and an enterprise value of $35.24 billion.
The stock is trading with a price-earnings ratio of 16.06, which is higher than 58% of companies in the Semiconductors industry. The stock price is currently 6.64% below its 52-week high and 56.70% above its 52-week low. The price-book ratio is 3.34.
Steven Cohen (Trades, Portfolio) is the company's largest guru shareholder with 0.99% of outstanding shares, followed by Larry Robbins (Trades, Portfolio) with 0.86% and Pioneer Investments with 0.55%.
Disclosure: I do not own any shares of any stocks mentioned in this article.
Read more here:
- 6 Stocks Outperforming the Benchmark
- 5 Stocks With Low Price-Sales Ratios
- 6 Companies That Are Expected to Grow Quickly
Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.
